Associations of Gestational and Childhood Urinary Triclosan Concentrations with Atopic and Allergic Symptoms in Health Outcomes and Measures of the Environment (HOME) Study Participants Ages 1-12 Years.
Saved in:
| Title: | Associations of Gestational and Childhood Urinary Triclosan Concentrations with Atopic and Allergic Symptoms in Health Outcomes and Measures of the Environment (HOME) Study Participants Ages 1-12 Years. |
|---|---|
| Authors: | Laue, Hannah E.1 hlaue@umass.edu, Fleury, Elvira S.2, Jackson-Browne, Medina S.3, Calafat, Antonia M.4, Chen, Aimin5, Yolton, Kimberly6,7, Cecil, Kim M.7,8, Newman, Nicholas C.6,7, Buckley, Jessie9, Lanphear, Bruce P.10, Braun, Joseph M.2 |
| Source: | Environmental Health Perspectives. Jun2026, Vol. 134 Issue 2, p139-147. 9p. |
| Subject Terms: | Eczema -- Risk factors, Risk assessment, Mathematical variables, Poisson distribution, Research funding, Child health services, Descriptive statistics, Triclosan, Longitudinal method, Respiratory allergy, Research, Disease susceptibility, Confidence intervals, Disease risk factors, Children, Pregnancy |
| Abstract: | BACKGROUND: Triclosan, an antimicrobial chemical that was widely used in consumer products, may increase risk of allergic diseases in children, but prospective studies are needed to clarify the association. OBJECTIVES: To elucidate the associations of time-varying urinary triclosan concentrations with eczema, allergic rhinitis, and wheeze. METHODS: In the HOME Study, a prospective pregnancy and birth cohort, we quantified urinary triclosan concentrations in mother-child pairs up to ten times between 16 weeks’ gestation and age 12 years. Caregivers reported eczema, allergic rhinitis, and wheeze symptoms biannually until children were aged 6 years and again when they were aged 8 and 12 years. We used generalized estimating equations to estimate the covariate-adjusted association of gestational and childhood triclosan concentrations with the risk of reporting eczema, allergic rhinitis, or wheezing symptoms. RESULTS: Three hundred forty-seven mother-child dyads contributed >3,000 visits to the analysis of gestational exposures and >2,600 visits to childhood analyses. Each 2-fold higher childhood triclosan concentration was associated with 1.23 (95% CI: 1.04, 1.46) and 1.12 (95% CI: 1.01, 1.25) times higher risk of reporting eczema and allergic rhinitis, respectively, but not wheezing (RR = 0.98 [95% CI: 0.82, 1.16]). We did not observe modification by child sex. Associations of gestational triclosan with eczema, allergic rhinitis, or wheezing symptoms were null in the full sample. Child sex modified the association of gestational triclosan with allergic rhinitis and wheezing (p-interactionAllergy: 0.02; p-interactionWheezing:0.10), with 1.09 (95% CI: 1.00, 1.19) and 0.91 (95% CI: 0.83, 1.00) times the risk of allergic rhinitis symptoms among males and females, respectively. CONCLUSION: Childhood urinary triclosan concentrations were associated with caregiver reported eczema and more weakly with allergic rhinitis. Associations of gestational triclosan with allergic outcomes differed by child sex, suggesting heightened susceptibility to triclosan among males. [ABSTRACT FROM AUTHOR] |
| Copyright of Environmental Health Perspectives is the property of National Institute of Environmental Health Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | GreenFILE |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | BACKGROUND: Triclosan, an antimicrobial chemical that was widely used in consumer products, may increase risk of allergic diseases in children, but prospective studies are needed to clarify the association. OBJECTIVES: To elucidate the associations of time-varying urinary triclosan concentrations with eczema, allergic rhinitis, and wheeze. METHODS: In the HOME Study, a prospective pregnancy and birth cohort, we quantified urinary triclosan concentrations in mother-child pairs up to ten times between 16 weeks’ gestation and age 12 years. Caregivers reported eczema, allergic rhinitis, and wheeze symptoms biannually until children were aged 6 years and again when they were aged 8 and 12 years. We used generalized estimating equations to estimate the covariate-adjusted association of gestational and childhood triclosan concentrations with the risk of reporting eczema, allergic rhinitis, or wheezing symptoms. RESULTS: Three hundred forty-seven mother-child dyads contributed >3,000 visits to the analysis of gestational exposures and >2,600 visits to childhood analyses. Each 2-fold higher childhood triclosan concentration was associated with 1.23 (95% CI: 1.04, 1.46) and 1.12 (95% CI: 1.01, 1.25) times higher risk of reporting eczema and allergic rhinitis, respectively, but not wheezing (RR = 0.98 [95% CI: 0.82, 1.16]). We did not observe modification by child sex. Associations of gestational triclosan with eczema, allergic rhinitis, or wheezing symptoms were null in the full sample. Child sex modified the association of gestational triclosan with allergic rhinitis and wheezing (p-interactionAllergy: 0.02; p-interactionWheezing:0.10), with 1.09 (95% CI: 1.00, 1.19) and 0.91 (95% CI: 0.83, 1.00) times the risk of allergic rhinitis symptoms among males and females, respectively. CONCLUSION: Childhood urinary triclosan concentrations were associated with caregiver reported eczema and more weakly with allergic rhinitis. Associations of gestational triclosan with allergic outcomes differed by child sex, suggesting heightened susceptibility to triclosan among males. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00916765 |
| DOI: | 10.1021/EHP.6c00019 |
